Dengue

MG Guzman, E Harris - The Lancet, 2015 - thelancet.com
Dengue viruses have spread rapidly within countries and across regions in the past few
decades, resulting in an increased frequency of epidemics and severe dengue disease …

A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010

RC Reiner Jr, TA Perkins… - Journal of The …, 2013 - royalsocietypublishing.org
Mathematical models of mosquito-borne pathogen transmission originated in the early
twentieth century to provide insights into how to most effectively combat malaria. The …

Antibody-dependent enhancement of severe dengue disease in humans

LC Katzelnick, L Gresh, ME Halloran, JC Mercado… - Science, 2017 - science.org
For dengue viruses 1 to 4 (DENV1-4), a specific range of antibody titer has been shown to
enhance viral replication in vitro and severe disease in animal models. Although suspected …

[PDF][PDF] How to design vector control efficacy trials: guidance on phase III vector control field trial design provided by the Vector Control Advisory Group

World Health Organization - 2017 - apps.who.int
Vector-borne diseases (VBDs), including malaria, dengue and leishmaniasis, cause
considerable morbidity and mortality in tropical regions of the world. Vector control methods …

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study

C Álvarez-Antonio, G Meza-Sánchez… - The Lancet Global …, 2021 - thelancet.com
Background Detection of anti-SARS-CoV-2 antibodies among people at risk of infection is
crucial for understanding both the past transmission of COVID-19 and vulnerability of the …

House-to-house human movement drives dengue virus transmission

ST Stoddard, BM Forshey… - Proceedings of the …, 2013 - National Acad Sciences
Dengue is a mosquito-borne disease of growing global health importance. Prevention efforts
focus on mosquito control, with limited success. New insights into the spatiotemporal drivers …

Dengue: knowledge gaps, unmet needs, and research priorities

LC Katzelnick, J Coloma, E Harris - The Lancet Infectious Diseases, 2017 - thelancet.com
Dengue virus is a mosquito-borne pathogen that causes up to about 100 million cases of
disease each year, placing a major public health, social, and economic burden on …

Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year

M Montoya, L Gresh, JC Mercado… - PLoS neglected …, 2013 - journals.plos.org
Four dengue virus serotypes (DENV1-4) circulate globally, causing more human illness than
any other arthropod-borne virus. Dengue can present as a range of clinical manifestations …

Human to mosquito transmission of dengue viruses

LB Carrington, CP Simmons - Frontiers in immunology, 2014 - frontiersin.org
The successful transmission of dengue virus from a human host to a mosquito vector
requires a complex set of factors to align. It is becoming increasingly important to improve …

Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort

LC Katzelnick, M Montoya, L Gresh… - Proceedings of the …, 2016 - National Acad Sciences
The four dengue virus serotypes (DENV1–4) are mosquito-borne flaviviruses that infect∼
390 million people annually; up to 100 million infections are symptomatic, and 500,000 …